Press Releases
Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment Japanese HCV patients...
Press Releases
genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists
Lyon, France, July 2, 2014 - genOway...
Research Insight
Reducing readmissions: Top strategy for improving quality, lowering costs
Dr. Fortuna says payers should consider expand their perspectives on improving the healthcare system by adopting the use of the tools, methodologies and quality...
News
Boehringer Ingelheim Statement on Hepatitis C drug development
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to move forward in this...
News
Soon, get HIV tests done at UK supermart
Britons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British sexual health charity...
News
US nets biggest penalties for fraud from pharma
The US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money recovered as penalties in...
News
Takeover drama between Pfizer and AstraZeneca reached PM’s door
The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In a letter to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read